As shown in Figure 2, Ga- and Lu-complexed PSMA-targeting ligands inhibited the binding of [18F]DCFPyL to LNCaP prostate cancer cells in a dose-dependent manner. This evidence concerns the gene FOLH1 and prostate cancer.